Clinical Trial Update: Omega-3 Fatty Acid-Based Parenteral Nutrition Improves Postoperative Recovery for Cirrhotic Patients With Liver Cancer [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating omega-3 fatty acid–based parenteral nutrition shows improved postoperative recovery in cirrhotic patients with liver cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cirrhosis
• Liver Cancer

Drugs mentioned

• omega-3 fatty acid-based parenteral nutrition

Snippet

Sponsor: Huazhong University of Science and Technology | Conditions: Liver Cancer, Cirrhosis | Phase 4 | Status: COMPLETED